NewsHK
has disclosed that its Series R Convertible Preferred Stock will convert into common stock at a five-to-one ratio, a move the company states will result in significant dilution for existing shareholders who do not hold the preferred shares.
The conversion is set to occur on November 2, 2026, under terms detailed in a Certificate of Designation filed as an exhibit to a Current Report on Form 8-K submitted to the U.S.
Securities and Exchange Commission on October 5, 2026. The company’s board of directors established October 13, 2026, as the record date and October 15, 2026, as the payment date for the preferred stock dividend.
Eligibility for this dividend is determined by holding common stock as of the record date. Jaguar Health noted that the specific ex-dividend date will be announced by the Nasdaq Stock Market once determined.
Keep reading